Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Clinical trial NCT05666336 · UNKNOWN
Trial details
- NCT number
- NCT05666336
- Sponsor
- Fen Li
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-31
- Primary completion
- 2024-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.